Ohmyhome Raises $1.6M in Private Placement at $0.30/Unit, Priced Above Market

summarizeSummary

Ohmyhome Ltd raised $1.6 million through a private placement of shares and warrants priced at $0.30 per unit, a premium to its current $0.2569 stock price. The deal includes warrants with a 5-year term and an aggressive alternate cashless exercise feature that could multiply dilution if the stock recovers.

check_boxKey Events · Financing and Capital Events · OMH

• Private Placement Priced at Premium

  Ohmyhome sold 5,333,331 shares and 5,333,331 warrants at a combined price of $0.30 per unit, raising $1.6 million in gross proceeds. The pricing is above the current market price of $0.2569, indicating investor confidence despite recent distress.

• Warrant Terms Create Overhang

  Each warrant is exercisable at $0.30 for 5 years, with a floor price of $0.10. After 7 days, holders can use an alternate cashless exercise to exchange each warrant for 9 shares, potentially causing severe dilution if the stock price appreciates.

• Capital Infusion Amid Nasdaq Deficiency

  The placement follows a July 16 Nasdaq deficiency notice for failing the $1.00 minimum bid price and a July 8 proposal for a reverse stock split. The $1.6 million provides working capital but does not resolve the listing compliance issue.

• Use of Proceeds for Working Capital

  The company intends to use the net proceeds for working capital and general corporate purposes, extending its operational runway.

auto_awesomeAnalysis · OMH · Real Estate & Construction

Ohmyhome Ltd has entered into a securities purchase agreement for a $1.6 million private placement, issuing 5.33 million shares and an equal number of warrants at a combined price of $0.30 per unit. The pricing represents a premium to the current market price of $0.2569, signaling institutional demand despite the company's recent distress signals — including a Nasdaq deficiency notice for failing the $1.00 minimum bid price and a proposed reverse stock split. The warrants are immediately exercisable at $0.30 with a 5-year term and contain an aggressive alternate cashless exercise feature that, after 7 days, allows holders to exchange each warrant for 9 shares, potentially leading to significant dilution if the stock price rises. The capital infusion provides critical working capital but comes with substantial overhang risk.